Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Acro Biomedical (ACBM) Shares Outstanding (2016 - 2025)

Acro Biomedical (ACBM) has 8 years of Shares Outstanding data on record, last reported at $60.0 million in Q4 2025.

  • For Q4 2025, Shares Outstanding changed 0.0% year-over-year to $60.0 million; the TTM value through Dec 2025 reached $60.0 million, changed 0.0%, while the annual FY2025 figure was $60.0 million, 0.0% changed from the prior year.
  • Shares Outstanding reached $60.0 million in Q4 2025 per ACBM's latest filing, roughly flat from $60.0 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $60.0 million in Q3 2021 and bottomed at $11.9 million in Q3 2022.
  • Average Shares Outstanding over 5 years is $56.7 million, with a median of $60.0 million recorded in 2021.
  • The widest YoY moves for Shares Outstanding: up 25.72% in 2021, down 0.0% in 2021.
  • A 5-year view of Shares Outstanding shows it stood at $60.0 million in 2021, then changed by 0.0% to $60.0 million in 2022, then changed by 0.0% to $60.0 million in 2023, then changed by 0.0% to $60.0 million in 2024, then changed by 0.0% to $60.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding were $60.0 million in Q4 2025, $60.0 million in Q3 2025, and $60.0 million in Q2 2025.